Beijing-based autonomous driving startup Haomo.AI has closed its Series A+ round. Separately, Jiangsu Synthgene Biotechnology, a provider of raw materials and related solutions to clients in the life sciences industry, has secured more than 300 million yuan ($47.
Read more: https://www.dealstreetasia.com/stories/haomo-ai-synthgene-288401/